Masitinib for treating amyotrophic lateral sclerosis [ID967]
Discontinued
Reference number: GID-TA10157
Suspended: The company has been unable to provide a submission for this appraisal within the required timelines. Therefore the appraisal will be put on hold and the committee meeting scheduled for 22 May 2018 will not take place. We will update you on any developments as soon as possible.